Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1968 6
1969 16
1970 34
1971 29
1972 39
1973 20
1974 42
1975 60
1976 69
1977 51
1978 77
1979 92
1980 103
1981 105
1982 149
1983 165
1984 193
1985 200
1986 196
1987 211
1988 174
1989 189
1990 216
1991 222
1992 199
1993 173
1994 190
1995 177
1996 150
1997 151
1998 116
1999 139
2000 142
2001 125
2002 139
2003 99
2004 153
2005 146
2006 161
2007 141
2008 127
2009 134
2010 131
2011 150
2012 165
2013 146
2014 110
2015 118
2016 97
2017 113
2018 79
2019 78
2020 82
2021 61
Text availability
Article attribute
Article type
Publication date

Search Results

6,289 results
Results by year
Filters applied: . Clear all
Page 1
Sulpiride for schizophrenia.
Soares BG, Fenton M, Chue P. Soares BG, et al. Cochrane Database Syst Rev. 2000;(2):CD001162. doi: 10.1002/14651858.CD001162. Cochrane Database Syst Rev. 2000. PMID: 10796605 Review.
SELECTION CRITERIA: All randomised or quasi-randomised clinical trials focusing on the use of different doses of sulpiride or comparing sulpiride to (i) placebo; (ii) typical antipsychotic drugs; or (iii) atypical antipsychotic drugs, for those with schizophrenia or …
SELECTION CRITERIA: All randomised or quasi-randomised clinical trials focusing on the use of different doses of sulpiride or compari …
Sulpiride: an antipsychotic with selective dopaminergic antagonist properties.
Caley CF, Weber SS. Caley CF, et al. Ann Pharmacother. 1995 Feb;29(2):152-60. doi: 10.1177/106002809502900210. Ann Pharmacother. 1995. PMID: 7756714 Review.
Early pharmacology reports hypothesized that sulpiride was selective for dopamine (D)2 receptors only, but sulpiride also blocks D3 and D4 receptors. ...The oral bioavailability of sulpiride is poor, with estimates approximating 35%. Sulpiride does not …
Early pharmacology reports hypothesized that sulpiride was selective for dopamine (D)2 receptors only, but sulpiride also bloc …
A risk-benefit assessment of sulpiride in the treatment of schizophrenia.
Mauri MC, Bravin S, Bitetto A, Rudelli R, Invernizzi G. Mauri MC, et al. Drug Saf. 1996 May;14(5):288-98. doi: 10.2165/00002018-199614050-00003. Drug Saf. 1996. PMID: 8800626 Review.
Sulpiride penetrates the blood-brain barrier poorly because of its low lipid solubility. ...It is still doubtful whether sulpiride is more effective than typical antipsychotics for the treatment of negative symptoms. ...
Sulpiride penetrates the blood-brain barrier poorly because of its low lipid solubility. ...It is still doubtful whether sulpiride
[Toxicity of sulpiride].
Ciszowski K, Szpak D, Wilimowska J. Ciszowski K, et al. Przegl Lek. 2010;67(8):606-9. Przegl Lek. 2010. PMID: 21387787 Review. Polish.
Sulpiride is a benzamide neuroleptic used in the treatment of some psychiatric and gastroenterological disorders. ...Elimination of sulpiride appears to depend primarily on the kidneys. The acute sulpiride poisoning includes mainly neuropsychiatric (i.e., agi
Sulpiride is a benzamide neuroleptic used in the treatment of some psychiatric and gastroenterological disorders. ...Elimination of
Effects of Various Methods of Sulpiride Administration on Prolactin Release in Horses.
Arana Valencia N, Thompson DL Jr, Southerland CV. Arana Valencia N, et al. J Equine Vet Sci. 2018 Sep;68:39-45. doi: 10.1016/j.jevs.2018.05.211. Epub 2018 May 26. J Equine Vet Sci. 2018. PMID: 31256886
Four experiments assessed factors affecting prolactin responses to sulpiride administration in horses. Experiment 1 compared the efficacy of the (-) enantiomer of sulpiride to that of the commonly used (+/-) racemic mixture. ...Experiment 2 compared the efficacy of …
Four experiments assessed factors affecting prolactin responses to sulpiride administration in horses. Experiment 1 compared the effi …
Sulpiride and breastfeeding.
Lasich AJ. Lasich AJ. S Afr Med J. 2005 Sep;95(9):624-6. S Afr Med J. 2005. PMID: 16327907 No abstract available.
The pharmacology of sulpiride--a dopamine receptor antagonist.
O'Connor SE, Brown RA. O'Connor SE, et al. Gen Pharmacol. 1982;13(3):185-93. doi: 10.1016/0306-3623(82)90088-x. Gen Pharmacol. 1982. PMID: 7047291 Review.
1. The clinical and experimental pharmacology of sulpiride, its effects on the CNS, gastrointestinal tract and cardiovascular system have been reviewed. 2. ...These properties are discussed with reference to the mechanisms of action of sulpiride and the classificati …
1. The clinical and experimental pharmacology of sulpiride, its effects on the CNS, gastrointestinal tract and cardiovascular system …
The mode of action of sulpiride as an atypical antidepressant agent.
Jenner P, Marsden CD. Jenner P, et al. Adv Biochem Psychopharmacol. 1982;32:85-103. Adv Biochem Psychopharmacol. 1982. PMID: 7046370 Review.
It can be said that sulpiride exerts a disinhibitory effect in both depression and schizophrenia but this is not associated with mechanisms through which typical antidepressant or anxiolytic agents act. Sulpiride acts selectively as a dopamine receptor antagonist in …
It can be said that sulpiride exerts a disinhibitory effect in both depression and schizophrenia but this is not associated with mech …
Sulpiride-induced tardive dystonia.
Miller LG, Jankovic J. Miller LG, et al. Mov Disord. 1990;5(1):83-4. doi: 10.1002/mds.870050119. Mov Disord. 1990. PMID: 1967484
Sulpiride is a selective D2-receptor antagonist with antipsychotic and antidepressant properties. ...We studied a 37-year-old man who developed persistent segmental dystonia within 2 months after starting sulpiride therapy. We could not find any previous reports of
Sulpiride is a selective D2-receptor antagonist with antipsychotic and antidepressant properties. ...We studied a 37-year-old man who
6,289 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page